(Q36553727)

14 August 2017

1 reference

title

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies (English)

1 reference

hypertrophic obstructive cardiomyopathy

14 August 2017

main subject

0 references

1 reference

Mahboob Alam

1

1 reference

14 August 2017

Hisham Dokainish

series ordinal

2

1 reference

14 August 2017

Nasser Lakkis

series ordinal

3

1 reference

14 August 2017

publication date

1 August 2006

1 reference

Journal of Interventional Cardiology

14 August 2017

published in

1 reference

14 August 2017

volume

19

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

319-327

1 reference

Hypertrophic cardiomyopathy: a systematic review

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

The management of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Postoperative and long-term prognosis of myotomy-myomectomy for obstructive hypertrophic cardiomyopathy: influence of associated mitral valve replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Percutaneous transluminal septal alcoholization for the treatment of refractory hypertrophic obstructive cardiomyopathy: initial experience in the Federal District

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

The case for surgery in obstructive hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Strain rate imaging for assessment of regional myocardial function: results from a clinical model of septal ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

The risk of alcohol leakage into the left anterior descending coronary artery during non-surgical myocardial reduction in patients with obstructive hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Transcoronary ablation of septal hypertrophy (TASH): a 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Mid-systolic septal deceleration. A new sign of left ventricular outflow tract obstruction obtained by color-coded tissue Doppler echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical septal reduction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Alcohol septal ablation complicated by complete heart block and permanent pacemaker failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Visualization of myocardial perfusion after percutaneous myocardial septal ablation for hypertrophic cardiomyopathy using superharmonic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Left ventricular opacification during selective intracoronary injection of echocardiographic contrast in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00153.X

10.1111/J.1540-8183.2006.00153.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference